Senior officials within the U.S. Food and Drug Administration's (FDA) tobacco center were reportedly blindsided by a sudden policy shift that permits unauthorized electronic cigarettes and nicotine pouches to enter the market prior to full regulatory vetting. The controversial guidelines, published just before former FDA Commissioner Marty Makary’s resignation, have sparked intense internal confusion and debate.
Traditionally, the FDA mandates strict scientific verification of health benefits for adult smokers before any new nicotine product can be legally sold. However, this new six-page memo breaks with that longstanding protocol, allowing certain products to launch before regulators complete their evaluations.
According to agency insiders, staff members tasked with enforcing vaping regulations were completely excluded from drafting the document, only discovering its existence hours before it went live. Former FDA tobacco director Mitch Zeller questioned the move, suggesting that subject matter experts may have opposed the policy and were subsequently bypassed to push it through.
The guidance bypassed the federally required public notice and comment period. Its release followed months of aggressive lobbying from tobacco and vape industry representatives targeting Makary. While Health and Human Services (HHS) defended the approach as a way to support adult smokers transitioning away from combustible tobacco, critics argue it undermines public trust in the FDA's regulatory independence.
Tech Reviewer & Vape Enthusiast
Rohan Sharma is a dynamic and analytical voice in the Indian vaping landscape, blending his passion for technology with a deep understanding of the global vape market. Based in Bangalore, India's tech hub, Rohan leverages his IT background to dissect the intricate details of vaping devices, from chipset performance to coil longevity. His content aims to empower the growing Indian vaping community with precise, data-driven reviews and practical advice.